Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Market: Market:

Cardiol Therapeutics (CRTPF)

Cardiol Therapeutics (CRTPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Cannabidiol Phase 1 Clinical Trial Launches, Targeting Inflammatory Heart Condition -- SECFilings.com Newsfile Corp - Wed Sep 16, 8:02AM CDT
CMTX - Wed Sep 16, 8:02AM CDT

Redondo Beach, California--(Newsfile Corp. - September 16, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference Newsfile Corp - Tue Sep 15, 7:08AM CDT
CMTX - Tue Sep 15, 7:08AM CDT

Oakville, Ontario--(Newsfile Corp. - September 15, 2020) - () () ("" or the ""), a leader in the development of pharmaceutical cannabidiol formulations for the treatment of cardiovascular diseases, including...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx(TM) Newsfile Corp - Wed Aug 26, 6:28AM CDT
CMTX - Wed Aug 26, 6:28AM CDT

Oakville, Ontario--(Newsfile Corp. - August 26, 2020) - () () ("" or the ""), a leader in the development of pharmaceutical cannabidiol formulations for the treatment of cardiovascular diseases, including...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Global Pandemic Creating Opportunities for Drug Companies to Earn Positive Market Attention PR Newswire - PRF - Thu Aug 6, 7:45AM CDT
CMTX - Thu Aug 6, 7:45AM CDT

, /PRNewswire/ -- In the last 18 years, viral disease epidemics have across the globe. Today's pandemic is quickly adding to the number of deaths while seriously disrupting economies, businesses, and...

GILD : 63.09 (-0.49%)
AZN : 55.66 (+0.40%)
PFE : 36.00 (-0.69%)
LLY : 149.81 (-0.03%)
CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Orphan Drug Designation Is Proven Path for CBD -- SECFilings.com Newsfile Corp - Wed Aug 5, 8:01AM CDT
CMTX - Wed Aug 5, 8:01AM CDT

Redondo Beach, California--(Newsfile Corp. - August 5, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Appoints CNBC Market Analyst Steven Grasso as Business Advisor Newsfile Corp - Mon Jun 29, 6:29AM CDT
CMTX - Mon Jun 29, 6:29AM CDT

Oakville, Ontario--(Newsfile Corp. - June 29, 2020) - () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
David Elsley Files Early Warning Report for Cardiol Therapeutics Newsfile Corp - Thu Jun 25, 4:04PM CDT
CMTX - Thu Jun 25, 4:04PM CDT

Oakville, Ontario--(Newsfile Corp. - June 25, 2020) - () () ("" or the ""), today announced that David Elsley, President and CEO of Cardiol, has filed an early warning report (the "Report") in respect...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Closes $17.25 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option Newsfile Corp - Thu Jun 4, 8:08AM CDT
CMTX - Thu Jun 4, 8:08AM CDT

Oakville, Ontario--(Newsfile Corp. - June 4, 2020) - () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart...

CRTPF : 1.8800 (-9.51%)
CRDL.TO : 2.48 (-10.14%)
Cardiol Therapeutics Reports 2020 AGM Results Newsfile Corp - Tue Jun 2, 2:46PM CDT
CMTX - Tue Jun 2, 2:46PM CDT

Oakville, Ontario--(Newsfile Corp. - June 2, 2020) - ( () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 1st at 4:30 p.m. EDT Newsfile Corp - Fri May 29, 8:38AM CDT
CMTX - Fri May 29, 8:38AM CDT

Oakville, Ontario--(Newsfile Corp. - May 29, 2020) - ( () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Announces Increase to Previously Announced Bought Deal Public Offering Newsfile Corp - Thu May 14, 8:45AM CDT
CMTX - Thu May 14, 8:45AM CDT

Oakville, Ontario--(Newsfile Corp. - May 14, 2020) - Cardiol Therapeutics Inc. ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Announces $11.25 Million Bought Deal Public Offering Newsfile Corp - Wed May 13, 4:46PM CDT
CMTX - Wed May 13, 4:46PM CDT

Oakville, Ontario--(Newsfile Corp. - May 13, 2020) - () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Files International Patent Application Covering the Use of Cannabidiol (CBD) to Improve the Outcome of Patients with COVID-19 Newsfile Corp - Wed May 6, 7:10AM CDT
CMTX - Wed May 6, 7:10AM CDT

Oakville, Ontario--(Newsfile Corp. - May 6, 2020) - Cardiol Therapeutics Inc. () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Announces Study Demonstrating its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart Newsfile Corp - Tue Apr 14, 6:30AM CDT
CMTX - Tue Apr 14, 6:30AM CDT

Oakville, Ontario--(Newsfile Corp. - April 14, 2020) -  () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure Newsfile Corp - Wed Apr 1, 6:28AM CDT
CMTX - Wed Apr 1, 6:28AM CDT

Oakville, Ontario--(Newsfile Corp. - April 1, 2020) - () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Announces Filing of 2019 Year-End Financial Statements and MD&A Newsfile Corp - Thu Mar 26, 5:06PM CDT
CMTX - Thu Mar 26, 5:06PM CDT

Oakville, Ontario--(Newsfile Corp. - March 26, 2020) - () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Hemp's Resurgence Continues as the FDA Hones in on CBD PR Newswire - Thu Mar 19, 8:00AM CDT
CMTX - Thu Mar 19, 8:00AM CDT

CBD has garnered a strong reputation for its wide range of potential health benefits. However, it has only been approved to treat childhood epilepsy syndromes, such as Dravet syndrome and Lennox-Gastaut...

IIPR : 118.13 (-5.19%)
CRTPF : 1.8800 (-9.51%)
CRDL.TO : 2.48 (-10.14%)
TLRY : 4.70 (-12.40%)
CRON : 5.05 (-4.90%)
OGI : 1.1100 (-6.72%)
Cardiol Therapeutics Signs Supplier Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc. Newsfile Corp - Wed Mar 18, 6:28AM CDT
CMTX - Wed Mar 18, 6:28AM CDT

Oakville, Ontario--(Newsfile Corp. - March 18, 2020) - () ()(""or the""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics Receives Health Canada Approval for Phase 1 Study of its Pharmaceutically Produced Cannabidiol (CBD) Formulation Newsfile Corp - Thu Mar 5, 6:28AM CST
CMTX - Thu Mar 5, 6:28AM CST

Oakville, Ontario--(Newsfile Corp. - March 5, 2020) - () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for heart...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Cardiol Therapeutics' Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada Newsfile Corp - Wed Jan 15, 6:14AM CST
CMTX - Wed Jan 15, 6:14AM CST

Oakville, Ontario--(Newsfile Corp. - January 15, 2020) - () () ("" or the ""), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for...

CRDL.TO : 2.48 (-10.14%)
CRTPF : 1.8800 (-9.51%)
Please wait...

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Tue Sep 8, 4:25PM CDT
See More
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
Reserve Your Spot